title: Regulation of apoptosis and caspase-8 expression in neuroblastoma cells by isoforms of the IG20 gene.
abstract: The IG20 gene undergoes alternative splicing resulting in the differential expression of six putative splice variants. Four of these (IG20pa, MADD, IG20-SV2, and DENN-SV) are expressed in virtually all human tissues. However, investigations examining alternative splicing of the IG20 gene to date have been largely limited to nonneural malignant and nonmalignant cells. In this study, we investigated the expression of alternative splice isoforms of the IG20 gene in human neuroblastoma cells. We found that six IG20 splice variants (IG20-SVs) were expressed in two human neuroblastoma cell lines (SK-N-SH and SH-SY5Y), highlighted by the expression of two unique splice isoforms (i.e., KIAA0358 and IG20-SV4). Similarly, we found enriched expression of these two IG20-SVs in human neural tissues derived from cerebral cortex, hippocampus, and, to a lesser extent, spinal cord. Using gain-of-function studies and siRNA technology, we determined that these "neural-enriched isoforms" exerted significant and contrasting effects on vulnerability to apoptosis in neuroblastoma cells. Specifically, expression of KIAA0358 exerted a potent antiapoptotic effect in both the SK-N-SH and SH-SY5Y neuroblastoma cell lines, whereas expression of IG20-SV4 had proapoptotic effects directly related to the activation of caspase-8 in these cells, which have minimal or absent constitutive caspase-8 expression. These data indicate that the pattern of expression of these neural-enriched IG20-SVs regulates the expression and activation of caspase-8 in certain neuroblastoma cells, and that manipulation of IG20-SV expression pattern may represent a potent therapeutic strategy in the therapy of neuroblastoma and perhaps other cancers.
authors.affiliation: Department of Neurology, University of Illinois at Chicago, Chicago, Illinois 60523, USA.
authors.forename: Liang Cheng
authors.initials: LC
authors.lastname: Li
authors.forename: Jian Rong
authors.initials: JR
authors.lastname: Sheng
authors.forename: Nirupama
authors.initials: N
authors.lastname: Mulherkar
authors.forename: Bellur S
authors.initials: BS
authors.lastname: Prabhakar
authors.forename: Matthew N
authors.initials: MN
authors.lastname: Meriggioli
mesh_terms: D056769:Alstrom Syndrome; D017398:Alternative Splicing; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D053181:Caspase 8 / Q000096:biosynthesis* / Q000378:metabolism; D061945:Caspase Inhibitors; D045744:Cell Line, Tumor; D053418:Death Domain Receptor Signaling Adaptor Proteins / Q000096:biosynthesis / Q000235:genetics*; D015536:Down-Regulation; D004789:Enzyme Activation; D053200:Fas-Associated Death Domain Protein / Q000378:metabolism; D020662:Guanine Nucleotide Exchange Factors / Q000096:biosynthesis / Q000235:genetics*; D006801:Humans; D009447:Neuroblastoma / Q000201:enzymology / Q000235:genetics* / Q000473:pathology*; D020033:Protein Isoforms; D034741:RNA, Small Interfering / Q000235:genetics; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D061945:Caspase Inhibitors; D053418:Death Domain Receptor Signaling Adaptor Proteins; C505533:FADD protein, human; D053200:Fas-Associated Death Domain Protein; D020662:Guanine Nucleotide Exchange Factors; C105852:MADD protein, human; D020033:Protein Isoforms; D034741:RNA, Small Interfering; D014409:Tumor Necrosis Factor-alpha; D053181:Caspase 8
references.citation: Biochem J. 2002 Mar 1;362(Pt 2):273-9
references.pmid: 11853534
references.citation: Int J Cancer. 2007 Jan 1;120(1):39-47
references.pmid: 17036321
references.citation: Cancer Res. 2000 Aug 15;60(16):4315-9
references.pmid: 10969767
references.citation: Oncogene. 2004 Feb 5;23(5):1076-87
references.pmid: 14716293
references.citation: Oncogene. 2004 Jul 15;23(32):5415-25
references.pmid: 15094781
references.citation: Oncogene. 2002 Apr 4;21(15):2295-308
references.pmid: 11948413
references.citation: Cell. 2003 Jul 25;114(2):181-90
references.pmid: 12887920
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14536-41
references.pmid: 12388783
references.citation: DNA Res. 1997 Apr 28;4(2):141-50
references.pmid: 9205841
references.citation: Nat Rev Cancer. 2003 Mar;3(3):203-16
references.pmid: 12612655
references.citation: J Biol Chem. 1997 May 2;272(18):12069-75
references.pmid: 9115275
references.citation: Lancet. 2007 Jun 23;369(9579):2106-20
references.pmid: 17586306
references.citation: Oncogene. 2001 Sep 13;20(41):5865-77
references.pmid: 11593392
references.citation: J Virol. 2003 Nov;77(22):11964-72
references.pmid: 14581533
references.citation: Nat Med. 2002 Dec;8(12):1333-5; author reply 1335
references.pmid: 12457155
references.citation: Science. 2002 Apr 19;296(5567):550-3
references.pmid: 11910072
references.citation: J Biol Chem. 2001 Dec 14;276(50):47202-11
references.pmid: 11577081
references.citation: Clin Cancer Res. 2008 Jan 15;14(2):347-51
references.pmid: 18223207
references.citation: Methods Enzymol. 2005;403:254-61
references.pmid: 16473592
references.citation: Genome. 1998 Aug;41(4):543-52
references.pmid: 9796103
references.citation: Nat Med. 2000 May;6(5):529-35
references.pmid: 10802708
references.citation: Cell. 2006 Jul 14;126(1):37-47
references.pmid: 16839875
references.citation: Cancer Res. 2003 Dec 15;63(24):8768-76
references.pmid: 14695193
references.citation: Oncogene. 2006 Oct 12;25(47):6252-61
references.pmid: 16682944
references.citation: Immunol Cell Biol. 2005 Jun;83(3):217-23
references.pmid: 15877598
references.citation: Cancer Res. 2003 Mar 1;63(5):1122-9
references.pmid: 12615731
references.citation: Neuron. 2006 Oct 5;52(1):93-101
references.pmid: 17015229
references.citation: Oncogene. 2004 Aug 12;23(36):6083-94
references.pmid: 15208670
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2586-91
references.pmid: 9482930
references.citation: Nature. 2006 Jan 5;439(7072):95-9
references.pmid: 16397500
references.citation: DNA Seq. 1996;6(5):263-73
references.pmid: 8988362
references.citation: Mol Biol Cell. 2001 May;12(5):1421-30
references.pmid: 11359932
references.citation: J Mol Med (Berl). 2001 Aug;79(8):428-36
references.pmid: 11511973
references.citation: J Biol Chem. 2007 Apr 20;282(16):11715-21
references.pmid: 17314102
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4210-5
references.pmid: 15007167